Status:
UNKNOWN
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Tuberculosis
Eligibility:
All Genders
18-99 years
Brief Summary
Tuberculosis is the third leading infectious killer. In 2021, an estimated 10,6 million people fell ill with tuberculosis worldwide. Drug resistance emerges with the increase of antibiotherapy use. Am...
Eligibility Criteria
Inclusion
- to be an adult,
- to have a diagnosis of tuberculosis
Exclusion
- pregnancy,
- disagreement to participate
Key Trial Info
Start Date :
January 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT06054334
Start Date
January 4 2023
End Date
October 1 2024
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens Picardie
Amiens, Picardie, France, 80054